Diebold Nixdorf (DBD) Cash Flow Statement

Click line-items for a historical chart and %

Net income	148.2M
Depreciation and amortization
Share-based compensation	10.1M
Excess tax benefits from share-based compensation	-200K
Devaluation of Venezuelan balance sheet	0
Impairment of intangible assets	0
Equity in earnings of an investee
Trade receivables	-94.4M
Inventories	-46.4M
Prepaid expenses
Other current assets
Accounts payable	-26.6M
Deferred revenue	-13M
Certain other assets and liabilities	-18.9M
Net cash used in operating activities	-206.2M
Proceeds from sale of discontinued operations
Proceeds from maturities of investments	107.1M
Proceeds from sale of investments
Payments for purchases of investments
Proceeds from sale of assets	400K
Capital expenditures
Increase in certain other assets	-9.3M
Collections on purchased finance receivables
Net cash provided by (used in) investing activities	-1.36B
Dividends paid	-38M
Debt issuance costs	-11.2M
Debt borrowings	1.81B
Debt repayments	-256.2M
Distribution of affiliates earnings to noncontrolling interest holders
Excess tax benefits from share-based compensation	200K
Issuance of common shares
Repurchase of common shares	-2M
Net cash provided by (used in) financing activities	1.58B
Effect of exchange rate changes on cash and cash equivalents	4.1M
Decrease in cash and cash equivalents	23.4M
Cash and cash equivalents at the beginning of the period	313.6M
Cash and cash equivalents at the end of the period	335.5M

Entities mentioned with DBD

View All Entities